77 phenotypes from 2 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Trappc9em1Xyli/Trappc9em1Xyli C57BL/6J-Trappc9em1Xyli	abnormal cerebellum morphology	J:304877
	abnormal corpus callosum morphology	J:304877
	abnormal dopaminergic neuron morphology	J:304877
	abnormal medulla oblongata morphology	J:304877
	abnormal motor learning	J:304877
	abnormal pons morphology	J:304877
	abnormal response to novel object	J:304877
	abnormal response to social novelty	J:304877
	astrocytosis	J:304877
	decreased brain size	J:304877
	decreased hippocampus volume	J:304877
	decreased locomotor activity	J:304877
	hippocampus atrophy	J:304877
	impaired spatial learning	J:304877
	increased aggression	J:304877
	increased body weight	J:304877
	increased striatum size	J:304877
	increased thigmotaxis	J:304877
	male infertility	J:304877
	reduced female fertility	J:304877
Trappc9tm1a(EUCOMM)Wtsi/Trappc9+ involves: C57BL/6N	abnormal social recognition	J:294716
	decreased brain weight	J:294716
	decreased exploration in new environment	J:294716
	increased body weight	J:294716
	paternal imprinting	J:294716
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi	abnormal cystic duct morphology	J:239583
	abnormal dorsal root ganglion morphology	J:239583
	abnormal inferior vena cava valve morphology	J:239583
	abnormal infrahyoid muscle connection	J:239583
	abnormal interatrial septum morphology	J:239583
	abnormal lateral ventricle morphology	J:239583
	abnormal pulmonary valve cusp morphology	J:239583
	abnormal urethra morphology	J:239583
	abnormal vibrissa morphology	J:211773
	absent ductus venosus valve	J:239583
	absent segment of posterior cerebral artery	J:239583
	blood in lymph vessels	J:239583
	decreased bone mineral content	J:211773
	decreased CD11b-low dendritic cell number	J:211773
	decreased gamma-delta T cell number	J:211773
	decreased grip strength	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased lean body mass	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	dual inferior vena cava	J:239583
	hemorrhage	J:239583
	heterochrony	J:239583
	impaired glucose tolerance	J:211773
	increased CD11b-high dendritic cell number	J:211773
	increased circulating insulin level	J:211773
	increased circulating sodium level	J:211773
	increased fasting circulating glucose level	J:211773
	increased hemangioma incidence	J:239583
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased total body fat amount	J:211773
	internal hemorrhage	J:239583
	multiple persisting craniopharyngeal ducts	J:239583
	thoracoschisis	J:239583
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi involves: C57BL/6N	abnormal cerebral cortex morphology	J:294716
	abnormal social recognition	J:294716
	decreased brain size	J:294716
	decreased brain weight	J:294716
	decreased cingulate cortex size	J:294716
	decreased corpus callosum size	J:294716
	decreased exploration in new environment	J:294716
	decreased hippocampal fimbria size	J:294716
	decreased primary motor cortex size	J:294716
	decreased substantia nigra size	J:294716
	impaired glucose tolerance	J:294716
	increased body fat mass	J:294716
	increased body weight	J:294716
	increased circulating cholesterol level	J:294716
	increased circulating glycerol level	J:294716
	increased circulating HDL cholesterol level	J:294716
	increased circulating insulin level	J:294716
	increased circulating LDL cholesterol level	J:294716
	increased circulating triglyceride level	J:294716
	increased lean body mass	J:294716
	microcephaly	J:294716
	obese	J:294716
	small thalamus	J:294716